Related Experiment Video
Updated: Mar 13, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
ApoptomiRs of Breast Cancer: Basics to Clinics
Shivani Sharma1, Praveen K Patnaik2, Stella Aronov2
1Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi New Delhi, India.
Abstract:
Apoptosis, a form of programmed cell death, is a highly regulated process, the deregulation of which has been associated with the tumor initiation, progression, and metastasis in various cancers including breast cancer. Induction of apoptosis is a popular target of various therapies currently being tested or used for breast cancer treatment. Thus, identifying apoptotic mediators and regulators is imperative for molecular biologists and clinicians for benefit of patients. The regulation of apoptosis is complex and involves a tight equilibrium between the pro- and anti-apoptotic factors. Recent studies have highlighted the role of miRNAs in the control of apoptosis and their interplay with p53, the master guardian of apoptosis. Here, we summarize and integrate the data on the role of miRNAs in apoptosis in breast cancer and the clinical advantage it may offer for the prognosis or treatment of breast cancer patients.
Insights
MicroRNAs (miRNAs) significantly regulate apoptosis, a key process in breast cancer development. Understanding these miRNA roles offers new therapeutic and prognostic strategies for breast cancer patients.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Deregulation of apoptosis, programmed cell death, is linked to breast cancer initiation, progression, and metastasis.
- Targeting apoptosis induction is a key strategy in breast cancer therapy.
- Identifying regulators of apoptosis is crucial for clinical applications.
Approach:
- This review integrates current data on microRNA (miRNA) involvement in breast cancer apoptosis.
- It explores the complex interplay between miRNAs, apoptotic factors, and p53.
- Focuses on the clinical implications of miRNAs in breast cancer prognosis and treatment.
Key Points:
- MicroRNAs play a critical role in controlling apoptosis.
- The balance between pro- and anti-apoptotic factors is tightly regulated by miRNAs.
- miRNAs interact with p53, a central regulator of apoptosis.
- Dysregulation of miRNAs contributes to breast cancer pathogenesis.
Conclusions:
- MicroRNAs are vital regulators of apoptosis in breast cancer.
- miRNAs hold significant potential for improving breast cancer prognosis.
- Targeting miRNA pathways may offer novel therapeutic avenues for breast cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
The Intrinsic Apoptotic Pathway
Apoptosis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

